Evidence map›Paper›PMID 26115166›Full record

ArticleVirology2015

Three cardiovirus Leader proteins equivalently inhibit four different nucleocytoplasmic trafficking pathways.

Jessica J Ciomperlik, Holly A Basta, Ann C Palmenberg

Abstract read
In one paragraph

Article in Virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Protein phosphatases at the nuclear envelope.Biochemical Society transactions · 2018
    Review
  17. Review
  18. Article
  19. Saffold virus, an emerging human cardiovirus.Reviews in medical virology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jessica J CiomperlikInstitute for Molecular Virology, and Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, United States.
Holly A BastaDepartment of Biology, Rocky Mountain College, Billings, MT, United States.
Ann C PalmenbergInstitute for Molecular Virology, and Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, United States. Electronic address: acpalmen@wisc.edu.

Funding

PROTEOLYTIC REGULATION OF PICORNAVIRAL MORPHOGENESISR01AI017331 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PALMENBERG, ANN C. · 1985 to 2013
$3.7M
Cardioviral Proteases and Comparative Genome StructureR56AI017331 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PALMENBERG, ANN C. · 2007 to 2007
$364k
NIAID NIH HHS AI017331NIAID NIH HHS R01 AI017331NIAID NIH HHS R56 AI017331
6 · The paper itself

Abstract

Cardiovirus infections inhibit nucleocytoplasmic trafficking by Leader protein-induced phosphorylation of Phe/Gly-containing nucleoporins (Nups). Recombinant Leader from encephalomyocarditis virus, Theiler׳s murine encephalomyelitis virus and Saffold virus target the same subset of Nups, including Nup62 and Nup98, but not Nup50. Reporter cell lines with fluorescence mCherry markers for M9, RS and classical SV40 import pathways, as well as the Crm1-mediated export pathway, all responded to transfection with the full panel of Leader proteins, showing consequent cessation of path-specific active import/export. For this to happen, the Nups had to be presented in the context of intact nuclear pores and exposed to cytoplasmic extracts. The Leader phosphorylation cascade was not effective against recombinant Nup proteins. The findings support a model of Leader-dependent Nup phosphorylation with the purpose of disrupting Nup-transportin interactions.

Indexed as

Host-Pathogen InteractionsActive Transport, Cell NucleusAnimalsEncephalomyocarditis virusHeLa CellsHumansMiceNuclear Pore Complex ProteinsProtein Processing, Post-TranslationalTheilovirusViral ProteinsNuclear Pore Complex ProteinsViral ProteinsCardiovirusLeader proteinNucleocytoplasmic trafficking inhibitionOkadaic acid

Identifiers

PMID26115166
PMCPMC4567469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.